Asian Spectator

Times Advertising

RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., November 20, 2020, /PRNewswire-AsiaNet/-- RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapyThe Phase 3 study is expected to recruit up to 125 patien...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Jangan asal FOMO padel: Tidak semua olahraga cocok buat tubuh kita

● Pilihan olahraga perlu menyesuaikan tipe tubuh.● Cara ini akan memaksimalkan aktivitas fisik dan kurangi risiko cedera.● Tipe tubuh memengaruhi kemampuan fisik membentuk otot dan m...

Bahaya bertanya ke AI: Separuh jawaban kesehatan menyesatkan, meski terdengar meyakinkan

Ilustrasi AI.Who is Danny/Shutterstock.comBayangkan kamu baru saja didiagnosis kanker stadium awal. Sebelum janji temu berikutnya dengan dokter, kamu bertanya ke chatbot berbasis kecerdasan buatan (AI...

Why Contractors Suction Hose Solutions Are Essential For Heavy-Duty Fluid Handling

In industries where materials move as relentlessly as time itself, equipment must match that intensity. Whether on construction sites, agricultural operations, or large-scale industrial setups, flui...